NASDAQ:PPD - PPD Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $43.36
  • Forecasted Upside: -6.91 %
  • Number of Analysts: 15
  • Breakdown:
  • 0 Sell Ratings
  • 12 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$46.58
▲ +0.06 (0.13%)
1 month | 3 months | 12 months
Get New PPD Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PPD and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PPD

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$43.36
▼ -6.91% Downside Potential
This price target is based on 15 analysts offering 12 month price targets for PPD in the last 3 months. The average price target is $43.36, with a high forecast of $48.00 and a low forecast of $35.00. The average price target represents a -6.91% upside from the last price of $46.58.

Hold

The current consensus among 15 polled investment analysts is to hold stock in PPD.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/21/2019
  • 0 strong buy ratings
  • 6 buy ratings
  • 8 hold ratings
  • 0 sell ratings
3/20/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 9 hold ratings
  • 0 sell ratings
6/18/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 9 hold ratings
  • 0 sell ratings
9/16/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 10 hold ratings
  • 0 sell ratings
12/15/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 8 hold ratings
  • 0 sell ratings
3/15/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 12 hold ratings
  • 0 sell ratings
5/14/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 12 hold ratings
  • 0 sell ratings
6/13/2021

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 12 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/28/2021JPMorgan Chase & Co.Reiterated RatingOverweight ➝ Neutral$48.00Low
i
4/26/2021Credit Suisse GroupReiterated RatingOutperform ➝ Neutral$42.00 ➝ $47.50Low
i
4/26/2021Jefferies Financial GroupReiterated RatingBuy ➝ HoldN/A
i
4/22/2021KeyCorpReiterated RatingOverweight ➝ Sector Weight$40.00Low
i
4/22/2021William BlairReiterated RatingOutperform ➝ Market PerformLow
i
Rating by J. Kreger at William Blair
4/22/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy ➝ Hold$39.00 ➝ $47.00Low
i
4/21/2021Robert W. BairdReiterated RatingOutperform ➝ Neutral$48.00N/A
i
4/20/2021Jefferies Financial GroupDowngradeBuy ➝ HoldLow
i
4/19/2021CitigroupDowngradeBuy ➝ NeutralLow
i
4/19/2021Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellReiterated RatingBuy ➝ Neutral$47.50Low
i
4/19/2021MizuhoDowngradeBuy ➝ NeutralLow
i
4/19/2021Credit Suisse GroupDowngradeOutperform ➝ Neutral$42.00 ➝ $47.50Low
i
4/16/2021TruistDowngradeBuy ➝ HoldLow
i
4/16/2021Evercore ISIDowngradeOutperformLow
i
4/16/2021Truist SecuritiesReiterated RatingBuy ➝ HoldMedium
i
4/16/2021William BlairDowngradeOutperform ➝ Market PerformMedium
i
Rating by J. Kreger at William Blair
4/16/2021Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$39.00 ➝ $47.00Medium
i
4/15/2021Robert W. BairdDowngradeOutperform ➝ Neutral$48.00High
i
3/2/2021BarclaysInitiated CoverageOverweight$42.00Low
i
2/25/2021CitigroupBoost Price Target$40.00 ➝ $42.00Low
i
2/25/2021Deutsche Bank AktiengesellschaftBoost Price TargetBuy$38.00 ➝ $39.00Medium
i
10/29/2020Deutsche Bank AktiengesellschaftBoost Price TargetBuy$33.00 ➝ $38.00Low
i
10/12/2020TruistInitiated CoverageBuy$42.00Medium
i
9/22/2020MizuhoBoost Price TargetBuy$35.00 ➝ $38.00Medium
i
9/21/2020Robert W. BairdBoost Price TargetAverage ➝ Outperform$36.00 ➝ $40.00Medium
i
9/15/2020KeyCorpBoost Price TargetOverweight$35.00 ➝ $37.00Medium
i
Rating by Donald Hooker at KeyCorp
8/6/2020MizuhoBoost Price TargetBuy$29.00 ➝ $35.00Low
i
Rating by Ann Hynes at Mizuho
8/6/2020CitigroupBoost Price TargetIn-Line ➝ Buy$31.00 ➝ $37.00Low
i
8/5/2020Morgan StanleyBoost Price TargetOverweight$30.00 ➝ $35.00High
i
Rating by Ricky Goldwasser at Morgan Stanley
8/5/2020Credit Suisse GroupBoost Price TargetOutperform$30.00 ➝ $35.00High
i
Rating by Erin Wright at Credit Suisse Group AG
6/4/2020KeyCorpInitiated CoverageOverweight$35.00High
i
Rating by Donald Hooker at KeyCorp
5/12/2020UBS GroupBoost Price TargetBuy$32.00 ➝ $35.00Medium
i
Rating by Daniel Brennan at UBS Group AG
5/12/2020Deutsche Bank AktiengesellschaftLower Price TargetBuy$33.00 ➝ $31.00Low
i
5/8/2020Morgan StanleyBoost Price TargetOverweight$26.00 ➝ $30.00High
i
Rating by Ricky Goldwasser at Morgan Stanley
5/8/2020MizuhoBoost Price TargetBuy$22.00 ➝ $29.00High
i
Rating by Ann Hynes at Mizuho
5/7/2020Credit Suisse GroupLower Price TargetOutperform$32.00 ➝ $30.00Medium
i
Rating by Erin Wright at Credit Suisse Group AG
4/28/2020UBS GroupLower Price TargetBuy$34.00 ➝ $32.00Low
i
Rating by Daniel Brennan at UBS Group AG
4/9/2020CitigroupLower Price TargetBuy$34.00 ➝ $26.00Medium
i
4/3/2020MizuhoLower Price TargetBuy$30.00 ➝ $22.00High
i
Rating by Ann Hynes at Mizuho
3/26/2020BarclaysLower Price TargetOverweight$33.00 ➝ $30.00Low
i
Rating by Jack Meehan at Barclays PLC
3/23/2020Jefferies Financial GroupUpgradeHold ➝ Buy$30.50 ➝ $20.00Medium
i
Rating by David Windley at Jefferies Financial Group Inc.
3/2/2020Jefferies Financial GroupInitiated CoverageHold$30.50High
i
3/2/2020Deutsche Bank AktiengesellschaftInitiated CoverageBuy$33.00High
i
3/2/2020JPMorgan Chase & Co.Initiated CoverageOverweight$35.00High
i
3/2/2020Bank of AmericaInitiated CoverageBuy$33.00High
i
3/2/2020UBS GroupInitiated CoverageBuy$34.00High
i
3/2/2020CitigroupInitiated CoverageBuy$34.00High
i
3/2/2020Robert W. BairdInitiated CoverageOutperform$35.00High
i
3/2/2020Morgan StanleyInitiated CoverageOverweight$34.00High
i
3/2/2020Evercore ISIInitiated CoverageOutperform$33.00High
i
3/2/2020Credit Suisse GroupInitiated CoverageOutperform$32.00High
i
3/2/2020MizuhoInitiated CoverageBuy$32.00High
i
3/2/2020William BlairInitiated CoverageOutperformHigh
i
Rating by J. Kreger at William Blair
3/2/2020The Goldman Sachs GroupInitiated CoverageBuy$34.00High
i
3/2/2020BarclaysInitiated CoverageOverweight$33.00High
i
(Data available from 6/14/2016 forward)
PPD logo
PPD, Inc., together with its subsidiaries, provides drug development services to the biopharmaceutical industry worldwide. The company operates through two segments, Clinical Development Services and Laboratory Services. It offers clinical development services, including product development and consulting, early development, Phases II-IV clinical trial management, accelerated enrollment, peri-and post-approval, and medical communications services. The company also provides laboratory services comprising bioanalytical, biomarker, vaccine science, good manufacturing practice, and central laboratory services. It serves pharmaceutical, biotechnology, medical device, and government organizations, as well as other industry participants. The company has a collaboration with Science 37 to design, build, test, implement, and execute digital trials using Science 37's DCT SaaS-based technology platform. PPD, Inc. was founded in 1985 and is headquartered in Wilmington, North Carolina.
Read More

Today's Range

Now: $46.58
$46.50
$46.60

50 Day Range

MA: $44.88
$37.84
$46.58

52 Week Range

Now: $46.58
$24.94
$46.60

Volume

944,500 shs

Average Volume

2,456,176 shs

Market Capitalization

$16.35 billion

P/E Ratio

87.89

Dividend Yield

N/A

Beta

2.22

Frequently Asked Questions

What sell-side analysts currently cover shares of PPD?

The following Wall Street research analysts have issued stock ratings on PPD in the last year: Barclays PLC, Citigroup Inc., Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell, Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Evercore ISI, Jefferies Financial Group Inc., JPMorgan Chase & Co., KeyCorp, Mizuho, Morgan Stanley, Robert W. Baird, Truist, Truist Securities, William Blair, and Zacks Investment Research.
View the latest analyst ratings for PPD.

What is the current price target for PPD?

11 Wall Street analysts have set twelve-month price targets for PPD in the last year. Their average twelve-month price target is $43.36, suggesting a possible downside of 6.9%. JPMorgan Chase & Co. has the highest price target set, predicting PPD will reach $48.00 in the next twelve months. Morgan Stanley has the lowest price target set, forecasting a price of $35.00 for PPD in the next year.
View the latest price targets for PPD.

What is the current consensus analyst rating for PPD?

PPD currently has 12 hold ratings and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in PPD, but not buy more shares or sell existing shares.
View the latest ratings for PPD.

What other companies compete with PPD?

How do I contact PPD's investor relations team?

PPD's physical mailing address is 929 NORTH FRONT STREET, WILMINGTON NC, 28401. The company's listed phone number is 910-251-0081 and its investor relations email address is [email protected] The official website for PPD is www.ppdi.com.